Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS3A pseudogene 6 is a processed pseudogene related to the ribosomal protein S3A gene, which encodes a structural component of the ribosomal 40S subunit. RPS3AP6 does not encode a functional protein and is classified as a pseudogene due to its lack of coding capacity and biological function. It shares sequence similarity with the ribosomal protein S3A gene but is not involved in protein synthesis or other well-defined biological processes[4][7][8]. There is no evidence that RPS3AP6 serves as a therapeutic target, nor are there known drugs, disease associations, or biomarker roles attributed to it. Its primary significance is as a genomic locus reflecting evolutionary duplication and inactivation of the parent RPS3A gene. This entry is not considered a clinically relevant target, receptor, enzyme, or biomarker; it is a molecular pseudogene with no established function or direct disease association[4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S3A pseudogene 6 (RPS3AP6).